Gérard Jaoue - Selected publications#


1. Metal carbonyl fragments as a new class of markers in molecular biology.
G. Jaouen, A. Vessières, S. Top, A. A. Ismail, I. S. Butler
J. Am. Chem. Soc., 1985, 107, 4778-4780. (72 citations)(seminal paper).

2. Bioorganometallic Chemistry – A Future Direction for Transition-Metal Organometallic Chemistry.
G. Jaouen, A. Vessières, I. S. Butler.
Acc. Chem. Res. , 1993, 26, 361-369. (228 citations).

3. Rhenium Carbonyl Complexes of Estradiol Derivatives with High Affinity for the Estradiol Receptor: An Approach to Selective Organometallic Radiopharmaceuticals
S. Top, H. El Hafa, A. Vessières, J. Quivy, J. Vaissermann, D. W. Hughes, M. J. McGlinchey, J-P Mornon, E. Thoreau et G. Jaouen
J. Am. Chem.Soc., 1995, 117, 8372-8380. (149 citations)

4. Bioorganometallic Chemistry: Structural Diversity of Organometallic Complexes with Bioligands and Molecular
Recognition Studies of Several Supramolecular Hosts with Biomolecules, Alkali-Metal Ions, and Organometallic Pharmaceuticals.
R. H. Fish, G. Jaouen
Organometallics , 2003, 22, 2166-2177. (180 citations).

5. Synthesis,biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: Evidence for an antiproliferative effect of hydroxyferociefens on both hormone-dependent and hormone-independent breast cancer cell lines.
S Top, A Vessières, G Leclercq, J. Quivy, J Tang, J Vaisser'mann, M Huche, G Jaouen.
Chemistry A European Journal, 2003, 9, 5223-5236. ( 171 citations).

6. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of anti-proliferative effects in vivo.
A. Vessières, S. Top, P. Pigeon, E. Hillard, L. Boubekeur, D. Spera, G. Jaouen
J. Med. Chem., 2005, 48, 3937-3940. (113 citations).

7. Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast cancer drug candidates.
E. Hillard, A. Vessières, L. Thouin, G. Jaouen, C. Amatore
Angew. Chem. Int. Ed., 45 (2006) 285-290. (138 citations).

8. Ferrocenyl Quinone methides as Strong Antiproliferative Agents: Formation by Metabolic and Chemical Oxidation of Ferrocenyl Phenols.
D. Hamels;P. Dansette; E. Hillard; S. Top; A. Vessières; P. Herson; G. Jaouen; D. Mansuy.
Angew. Chem.. Int. Ed., 2009, 48, 9124-9126. (25 citations).

9. A [3]Ferrocenophane Polyphenol Showing a Remarkade Antiproliferative Activity on Breast and Prostate Cancer Cell Lines.
D. Plazuk; A. Vessières; E. Hillard; O. Buriez; E. Labbe; P. Pigeon; M-A. Plamont; C. Amatore; J. Zakrewski; G. Jaouen.
J. Med. Chem., 2009, 52, 4964-4967. (22 citations)

10. Local delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft.
E. Allard; D. Jarnet; A. Vessières; S. Vinchon-Petit; G. Jaouen; J-P. Benoit ; C. Passirani.
Pharm. Res., 2010, 27, 56-64. (9 citations).

11. Bioorganometallics : Future Trends in Drug Discovery, Analytical Chemistry, and Catalysis.
E. Hillard; G. Jaouen.
Organometallics, 2011, 30, 20-27. (among the most read articles in 2011) (25 citations).

Editor of two recent books:

Bioorganometallics, Wiley VCH 2006; Medicinal Organometallic Chemistry, Springer Verlag, 2010.

Metrics: about 400 papers, 14 patents, 17 reviews, 196 invited lectures, h index : 44, 8570 citations.

Imprint Privacy policy   « This page (revision-2) was last updated on Wednesday, 17. October 2012, 23:04 by Kaiser Dana
  • operated by